Description
CV-65 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
CV-65 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
| Purity | ≥70% |
|---|---|
| Formula | C14H10N2O4 |
| Formula Wt. | 270.24 |
| Chemical Name | 3,6-Dimethyl-1,8-diazaanthracene-2,7,9,10(1H,8H)-tetrone |
| IUPAC Name | 3,7-dimethyl-1,9-dihydropyrido[3,2-g]quinoline-2,5,8,10-tetrone |
| Appearance | Orange Solid |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Negative control for PKC activation.
Protease inhibitor.
SRPK1 inhibitor.
Flavonoid found in Epimedium.
Cyclic dinucleotide that detects cytosolic DNA ...
Pyrimidine nucleoside (cytidine) analog; DNA ch...
Proteasome antigen.
Thienylbutyl ITC analog.
Endogenous peptide hormone fragment, involved i...
NSAID; COX-1/2 inhibitor.
NSAID; COX-1/2 inhibitor.
SERCA inhibitor.
Iridoid glucoside found in Eucommia, Castilleja...
PDGFR inhibitor.
Histamine H2 antagonist, GSK-3β inhibitor.
Diclofenac analog, NSAID; COX-2 inhibitor.
Fermentation impurity
Non-steroid; AR antagonist.
Statin; HMG-CoA reductase inhibitor.
B-Raf and c-Raf inhibitor.